Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 11.02.2021.

#innovative
#200KChallenge
#entrepreneurs
#startups
#medicaldevice
#investors
#biotech

Startups

@matthewherper shared
On Feb 6, 2021
Why Opening Restaurants Is Exactly What the Coronavirus Wants Us to Do. By ⁦@CarolineYLChen⁩. https://t.co/nZ6aJPakU4
Open
Why Opening Restaurants Is Exactly What the Coronavirus Wants Us to Do

Why Opening Restaurants Is Exactly What the Coronavirus Wants Us to Do

Governors continue to open indoor dining and other activities before vaccinations become widespread. Experts warn this could create superspreading playgrounds for dangerous variants and ...

@businessinsider shared
On Feb 9, 2021
RT @ajs: Meet 22 women who launched and led startups to an IPO, an accomplishment few female founders have ever reached. @WhitWolfeHerd will become the youngest to accomplish (age 31) this when Bumble goes public this week. https://t.co/1c8fqD5lL5 https://t.co/w8OCO1Ww2o
Open
Meet 22 women who launched and led startups to an IPO, an accomplishment few female founders have ever reached

Meet 22 women who launched and led startups to an IPO, an accomplishment few female founders have ever reached

These women have founded and led public companies from Eventbrite to BlackLine. Some are worth billions.

@MALifeSciences shared
On Feb 7, 2021
RT @UMassM2D2: The 10th annual #200KChallenge is THE event for #medicaldevice and #biotech #entrepreneurs and #investors! On March 24th, #innovative #startups from around the globe will pitch to win a share of $200K in in-kind services. Tickets: https://t.co/cbmJnYadPm https://t.co/gkQz4sbv4z
Open
Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, Academics, Students, and Life Sciences Industry Professionals:

Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, Academics, Students, and Life Sciences Industry Professionals:

In response to the coronavirus pandemic, we're taking our signature pitch event online. Join us — REGISTRATION IS FREE!

@BiotechWorld shared
On Feb 10, 2021
Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors https://t.co/jjjChAY6pC https://t.co/GLUsWZCWWU
Open
Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors

Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors

The adeno-associated viruses often used as vectors to deliver gene therapy can trigger unwanted and sometimes dangerous immune responses. Now, a Harvard University team led by renowned ...

@businessinsider shared
On Feb 5, 2021
Insider Cannabis: A biotech makes a $7.2 billion bet on medical marijuana — Top cannabis VCs lay out 2021 predictions — Psychedelic startups raising millions https://t.co/acPPfL9zrn
Open
A biotech makes a $7.2 billion bet on medical marijuana

A biotech makes a $7.2 billion bet on medical marijuana

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

@JohnCendpts shared
On Feb 4, 2021
The first weekly Endpoints Manufacturing report is out. From @ConnerMitchell0 and @ka_blankenship -- Check it out. You can never know too much about manufacturing in this business. https://t.co/MbQ7NdgiyA
Open
4 February, 2021

4 February, 2021

I'll be keeping an eye on a few key areas this year across biotech manufacturing: the continued rollout of Covid-19 vaccines and related therapeutics, the status of the various …

@FierceBiotech shared
On Feb 8, 2021
Mullen, who will also remain as Editas’ chairman, is parachuted in as Collins leaves next week, coming off some big roles, including as Biogen’s former CEO https://t.co/070kNolis4
Open
Ex-Biogen chief and Editas chair Mullen becomes CRISPR biotech's new CEO amid C-suite shake-up

Ex-Biogen chief and Editas chair Mullen becomes CRISPR biotech's new CEO amid C-suite shake-up

Cynthia Collins is out as Editas Medicine’s CEO as chairman James Mullen takes over from Feb. 15 after the biotech lost its Allergan/AbbVie partnership on its leading eye disease drug ...

@MNakada shared
On Feb 5, 2021
Deborah Geraghty now CEO of Anokion. Congrats Deb! https://t.co/A1UZOtgEUW
Open
Deborah Geraghty, PhD

Deborah Geraghty, PhD

Dr. Geraghty joined Anokion in 2018 as Chief Business Officer and was most recently Chief Operating Officer of the company. Dr. Geraghty brings more than 20 years of extensive experience in ...